| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 142, 471-480, Copyright © 1993 by American Society for Investigative Pathology
REGULAR ARTICLES |
G Montrucchio, G Alloatti, F Mariano, A Comino, G Cacace, R Polloni, PG De Filippi, G Emanuelli and G Camussi
Dipartimento di Fisiopatologia Clinica, Ospedale Maggiore di S. Giovanni Battista e della Citta di Torino, Italy.
This study investigated the role of platelet-activating factor in the recruitment of polymorphonuclear neutrophils (PMN) in a rabbit model of cardiac ischemia and reperfusion. The accumulation of PMN was evaluated 2 and 24 hours after removal of 40 minutes of coronary occlusion by morphometric analysis and 111In-labeled PMN infiltration. The administration of two structurally unrelated platelet-activating factor- receptor antagonists (SDZ 63-675, 5 mg/kg body weight, and WEB 2170, 5 mg/kg body weight) before reperfusion significantly reduced the accumulation of PMN, as well as the hemodynamic alterations and the size of necrotic area. Two hours after reperfusion, the percentage of increase of 111In-labeled PMN in transmural central ischemic zone was significantly reduced in rabbits pretreated with SDZ 63-675 (51.4 +/- 7.9) or WEB 2170 (32.4 +/- 8.8) with respect to untreated rabbits (107.6 +/- 13.5). The morphometric analysis of myocardial sections confirmed the reduction of PMN infiltration at 2 hours and demonstrated that at 24 hours the phenomenon was even more significant. In addition, SDZ 63-675 and WEB 2170 prevented early transient bradycardia and hypotension and reduced the infarct size, judged by staining with tetrazolium at 2 and 24 hours after reperfusion, and by histological examination at 24 hours. These results suggest that platelet-activating factor is involved in the accumulation of PMN in the reperfused ischemic myocardium and contributes to the evolution of myocardial injury.
This article has been cited by other articles:
 |
|
 |
|
  J. Vinten-Johansen Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury Cardiovasc Res, February 15, 2004; 61(3): 481 - 497. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Montrucchio, G. Alloatti, and G. Camussi Role of Platelet-Activating Factor in Cardiovascular Pathophysiology Physiol Rev, October 1, 2000; 80(4): 1669 - 1699. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.-M. Hung, J.-K. Chen, S.-S. Huang, R.-S. Lee, and M.-J. Su Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes Cardiovasc Res, August 18, 2000; 47(3): 549 - 555. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. N. Morgan, E. M. Boyle Jr, W. Yun, J. C. Kovacich, T. G. Canty Jr, E. Chi, T. H. Pohlman, and E. D. Verrier Platelet-Activating Factor Acetylhydrolase Prevents Myocardial Ischemia-Reperfusion Injury Circulation, November 9, 1999; 100(90002): II-365 - 368. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Qayumi, J. C. English, D. V. Godin, D. M. Ansley, E. B. Loucks, J. U. Lee, and C.-W. Kim The Role of Platelet-Activating Factor in Regional Myocardial Ischemia-Reperfusion Injury Ann. Thorac. Surg., June 1, 1998; 65(6): 1690 - 1697. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Montrucchio, E. Lupia, A. De Martino, L. Silvestro, S. R. Savu, G. Cacace, P.G. De Filippi, G. Emanuelli, and G. Camussi Plasmin Promotes an Endothelium-Dependent Adhesion of Neutrophils : Involvement of Platelet Activating Factor and P-Selectin Circulation, June 15, 1996; 93(12): 2152 - 2160. [Abstract] [Full Text]
|
|
|
|
|
|
K. J. Zehr, R. S. Poston, P. C. Lee, K. Uthoff, P. Kumar, P. W. Cho, A. M. Gillinov, J. M. Redmond, J. A. Winkelstein, A. Herskowitz, et al. Platelet Activating Factor Inhibition Reduces Lung Injury After Cardiopulmonary Bypass Ann. Thorac. Surg., February 1, 1995; 59(2): 328 - 335. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
